- ICH GCP
- Rejestr badań klinicznych w USA
- Badanie kliniczne NCT03300154
Effectiveness of Financial Incentives and Text Messages to Improve Health Care in Population With Moderate and High Cardiovascular Risk
Effectiveness of Financial Incentives and Text Messages to Improve Health Care of Vulnerable Population With Moderate and High Cardiovascular Risk in Argentina: A Randomized Cluster Trial
Cardiovascular diseases are increasing throughout the developing world and are the cause of almost 16.7 million deaths each year, of which 80% occur in low and middle-income countries. As more than three fourth of the global burden of cardiometabolic diseases are related to risk factors connected with lifestyles or behaviors, such as smoking, unhealthy eating, low physical activity, and harmful consumption of alcohol. This burden could be dramatically reduced by changing individual behaviors. This study is focused on interventions that are aimed to improve the adherence to treatment in cardiovascular disease (hypertension), based on a Behavioral Economics approach. Most of public policies targeted to tackle NCDs utilize a rational economic model of behavior. Behavioral economics, by using insights from cognitive psychology and other social sciences, has drawn a lot of attention for its potential to increase healthy behaviors. Interventions informed by BE principles seek to rearrange the social or physical environment in such a way to 'nudge' people towards healthier choices and behaviors.
Main objective: to assess whether the implementation of two strategies based on behavioral economics, that include the use of a financial incentive scheme and specific framing to beneficiaries (i.e. mobile health interventions), increase the referral, evaluation and follow-up of people with moderate and high cardiovascular risk in the public health network, compared to the usual strategy.
Design: A cluster-randomized pragmatic clinical trial will be performed. The randomization unit will be the Community Health Centers (CHC) and the intervention groups (2 arms) or control will be assigned to 9 health centers in total (3 CHC per arm).
Population: This RCT is going to be conducted in selected CHC of Salta. Nine CHC will be selected, which will be randomized: 3 centers to the control, 3 centers to framing intervention with messages and 3 centers to the intervention with incentives.
A total of 900 patients ≥ 40 years, without health coverage and with a 10-year cardiovascular risk ≥ 10% will participate in this study.
Follow up: 3 month
Przegląd badań
Status
Interwencja / Leczenie
Typ studiów
Zapisy (Rzeczywisty)
Faza
- Nie dotyczy
Kontakty i lokalizacje
Lokalizacje studiów
-
-
Salta
-
Guemes, Salta, Argentyna, 4400
- 1º DE MAYO
-
Guemes, Salta, Argentyna, 4400
- Barrio Cooperativa
-
Guemes, Salta, Argentyna, 4400
- Barrio La Tablada
-
Guemes, Salta, Argentyna, 4400
- Campo Santo
-
Guemes, Salta, Argentyna, 4400
- CIC
-
Guemes, Salta, Argentyna, 4400
- EL BORDO
-
Guemes, Salta, Argentyna, 4400
- El cruce
-
Guemes, Salta, Argentyna, 4400
- Villa Tranquila
-
Güemes, Salta, Argentyna, 4400
- Los Olivos
-
-
Kryteria uczestnictwa
Kryteria kwalifikacji
Wiek uprawniający do nauki
Akceptuje zdrowych ochotników
Płeć kwalifikująca się do nauki
Opis
Inclusion Criteria:
- Subjects that only have public health coverage.
- Residence in the area of influence of the health centers of the study.
- Have a mobile phone for personal use.
- 10 year cardiovascular risk ≥ 10%
Exclusion Criteria:
- Pregnant women.
- Immobilized people.
- Persons who do not give their informed consent.
- People planning to move in the next 3 months
Plan studiów
Jak projektuje się badanie?
Szczegóły projektu
- Główny cel: Zapobieganie
- Przydział: Randomizowane
- Model interwencyjny: Przydział równoległy
- Maskowanie: Brak (otwarta etykieta)
Broń i interwencje
Grupa uczestników / Arm |
Interwencja / Leczenie |
|---|---|
|
Brak interwencji: Zwykła opieka
|
|
|
Eksperymentalny: Financial incentives
|
The study nurses will schedule an appointment with the doctor at the health center, within 4 weeks from the participant's inclusion in the study.
Participants who attend the first visit at the health center will receive a direct incentive consisting of the payment of a limited amount to be determined (approximately AR $ 150-200) through a shopping voucher for the amount mentioned.
Participants attending the follow-up visit at the health center within 3 months from their inclusion in the study will participate in a lottery.
The lottery will offer the possibility of winning a new voucher with a probability of 1 in 3. Participants who do not attend the health center will not receive any incentive.
|
|
Eksperymentalny: Framing (SMS)
|
After inclusion, participants will receive weekly text messages (SMS) using a specific framing or formulation of the message, highlighting the potential benefits and positive aspects of health care.
These messages will promote follow-up visits, adherence to treatment, and benefits to be gained from a follow-up visit with the physician.
Messages will be sent with a frequency of two per week during the first 30 days and then 1 per week until the end of the follow-up.
These messages will have no cost to participants.
|
Co mierzy badanie?
Podstawowe miary wyniku
Miara wyniku |
Opis środka |
Ramy czasowe |
|---|---|---|
|
Attendance at the first medical visit
Ramy czasowe: 4 weeks
|
Proportion of patients who attended and completed the first clinical visit to the health center
|
4 weeks
|
|
Attendance at the second medical visit
Ramy czasowe: 8 weeks after first medical visit
|
Proportion of patients who attended and completed the second clinical visit to the health center
|
8 weeks after first medical visit
|
Miary wyników drugorzędnych
Miara wyniku |
Opis środka |
Ramy czasowe |
|---|---|---|
|
Attendance at least one clinical visit
Ramy czasowe: 12 weeks
|
Proportion of patients who attended and completed at least one clinical visit to the health
|
12 weeks
|
Współpracownicy i badacze
Współpracownicy
Publikacje i pomocne linki
Daty zapisu na studia
Główne daty studiów
Rozpoczęcie studiów (Rzeczywisty)
Zakończenie podstawowe (Rzeczywisty)
Ukończenie studiów (Oczekiwany)
Daty rejestracji na studia
Pierwszy przesłany
Pierwszy przesłany, który spełnia kryteria kontroli jakości
Pierwszy wysłany (Rzeczywisty)
Aktualizacje rekordów badań
Ostatnia wysłana aktualizacja (Rzeczywisty)
Ostatnia przesłana aktualizacja, która spełniała kryteria kontroli jakości
Ostatnia weryfikacja
Więcej informacji
Terminy związane z tym badaniem
Inne numery identyfikacyjne badania
- AR-T1087-P0001/2
Informacje o lekach i urządzeniach, dokumenty badawcze
Bada produkt leczniczy regulowany przez amerykańską FDA
Bada produkt urządzenia regulowany przez amerykańską FDA
Te informacje zostały pobrane bezpośrednio ze strony internetowej clinicaltrials.gov bez żadnych zmian. Jeśli chcesz zmienić, usunąć lub zaktualizować dane swojego badania, skontaktuj się z register@clinicaltrials.gov. Gdy tylko zmiana zostanie wprowadzona na stronie clinicaltrials.gov, zostanie ona automatycznie zaktualizowana również na naszej stronie internetowej .